Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity - PubMed (original) (raw)

Comparative Study

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity

A Ashkenazi et al. Proc Natl Acad Sci U S A. 1991.

Erratum in

Proc Natl Acad Sci U S A 1992 Feb 15;89(4):1517

Abstract

The infection of human cells by laboratory strains of human immunodeficiency virus type 1 (HIV-1) can be blocked readily in vitro by recombinant soluble CD4 and CD4-immunoglobulin hybrid molecules. In contrast, infection by primary isolates of HIV-1 is much less sensitive to blocking in vitro by soluble CD4-based molecules. To investigate the molecular basis for this difference between HIV-1 strains, we isolated the gp120-encoding genes from several CD4-resistant and CD4-sensitive HIV-1 strains and characterized the CD4-binding properties of their recombinant gp120 (rgp120) products. Extensive amino acid sequence variation was found between the gp120 genes of CD4-resistant and CD4-sensitive HIV-1 isolates. However, the CD4-binding affinities of rgp120 from strains with markedly different CD4 sensitivities were essentially the same, and only small differences were observed in the kinetics of CD4 binding. These results suggest that the lower sensitivity of primary HIV-1 isolates to neutralization by CD4-based molecules is not due to lower binding affinity between soluble CD4 and free gp120.

PubMed Disclaimer

Cited by

Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
Mesa KA, Yu B, Wrin T, Petropoulos CJ, Pogson GH, Alexander DL, Perez G, O'Rourke SM, Sinangil F, Robinson J, Conant MA, Berman PW. Mesa KA, et al. PLoS One. 2019 Apr 10;14(4):e0213409. doi: 10.1371/journal.pone.0213409. eCollection 2019. PLoS One. 2019. PMID: 30969970 Free PMC article.
Glycans flanking the hypervariable connecting peptide between the A and B strands of the V1/V2 domain of HIV-1 gp120 confer resistance to antibodies that neutralize CRF01_AE viruses.
O'Rourke SM, Sutthent R, Phung P, Mesa KA, Frigon NL, To B, Horthongkham N, Limoli K, Wrin T, Berman PW. O'Rourke SM, et al. PLoS One. 2015 Mar 20;10(3):e0119608. doi: 10.1371/journal.pone.0119608. eCollection 2015. PLoS One. 2015. PMID: 25793890 Free PMC article.
Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumab.
Toma J, Weinheimer SP, Stawiski E, Whitcomb JM, Lewis ST, Petropoulos CJ, Huang W. Toma J, et al. J Virol. 2011 Apr;85(8):3872-80. doi: 10.1128/JVI.02237-10. Epub 2011 Feb 2. J Virol. 2011. PMID: 21289125 Free PMC article.
Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus.
O'Rourke SM, Schweighardt B, Phung P, Fonseca DP, Terry K, Wrin T, Sinangil F, Berman PW. O'Rourke SM, et al. J Virol. 2010 Nov;84(21):11200-9. doi: 10.1128/JVI.00790-10. Epub 2010 Aug 11. J Virol. 2010. PMID: 20702624 Free PMC article.
Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange.
Cerutti N, Mendelow BV, Napier GB, Papathanasopoulos MA, Killick M, Khati M, Stevens W, Capovilla A. Cerutti N, et al. J Biol Chem. 2010 Aug 13;285(33):25743-52. doi: 10.1074/jbc.M110.144121. Epub 2010 Jun 10. J Biol Chem. 2010. PMID: 20538591 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7139-43 - PubMed
1. Nature. 1989 Feb 9;337(6207):525-31 - PubMed
1. Science. 1987 Dec 18;238(4834):1704-7 - PubMed
1. Science. 1987 May 15;236(4803):819-22 - PubMed
1. Nature. 1990 Apr 12;344(6267):667-70 - PubMed

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity - PubMed (original) (raw)